Filter
1460
Filtered Results: 1460
Text search:
Ministry
of
Health,
Department
of
Drug
Administration
Featured
Recommendations
134
New Publications
498
Language
Document type
No document type
937
Guidelines
194
Studies & Reports
183
Manuals
69
Strategic & Response Plan
52
Training Material
18
Situation Updates
4
Fact sheets
3
Countries / Regions
India
125
Kenya
79
Nigeria
50
Ethiopia
50
Uganda
48
Tanzania
47
Myanmar / Burma
43
Nepal
39
Liberia
39
Ghana
38
Zambia
37
Western and Central Europe
32
Malawi
28
Global
28
Sierra Leone
27
Rwanda
24
Bangladesh
24
Latin America and the Carribbean
23
Eastern Europe
18
Ukraine
17
Africa
16
Namibia
15
Zimbabwe
14
Botswana
13
Cambodia
12
Lesotho
10
South–East Asia Region
10
South Africa
10
Mozambique
9
Eswatini/ Swaziland
8
Asia
7
Indonesia
7
Tajikistan
6
Philippines
6
South Sudan
6
Thailand
5
Cameroon
5
Senegal
5
East and Southern Africa
5
Russia
5
Georgia
5
Syria
4
Albania
4
Laos
4
Jordan
4
Congo, Democratic Republic of
4
Middle East and North Africa
4
Paraguay
4
Sudan
4
Pakistan
4
Timor Leste/ East Timor
3
China
3
Burkina Faso
3
Haiti
3
Germany
3
Eastern Europe and Central Asia
3
Iran
2
West and Central Africa
2
Vietnam
2
Sri Lanka
2
Poland
2
North Macedonia
1
Colombia
1
Serbia
1
Turkey
1
Benin
1
Gambia
1
Kazakhstan
1
Fiji
1
Singapore
1
Estonia
1
Kyrgyzstan
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Venezuela
1
Hungary
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Bolivia
1
Argentina
1
Lebanon
1
Papua New Guinea
1
Brazil
1
Moldova
1
Romania
1
Greece
1
Palestine
1
Mali
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
791
Clinical Guidelines
118
Public Health
56
Women & Child Health
46
Key Resources
43
Pharmacy & Technologies
15
Capacity Building
13
Toolboxes
TB
115
HIV
110
Mental Health
85
NTDs
75
AMR
68
Pharmacy
56
COVID-19
41
Rapid Response
38
Caregiver
31
Malaria
28
Ebola & Marburg
17
Refugee
13
Conflict
12
Planetary Health
11
NCDs
10
Disability
8
Global Health Education
7
Health Financing Toolbox
6
Specific Hazards
5
Natural Hazards
5
Zika
4
Polio
4
Cholera
3
Social Ethics
3
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public health specialists, clinicians and o...
The Infection Prevention and Control (IPC) Assessment Framework (IPCAF) is a tool to support the implementation of the World Health Organization (WHO) Guidelines on core components of IPC programmes at the acute health care facility level. The user should be familiar with the contents of these guide...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through the Triple Billion Goal”. The staff outlined pri...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
A summary of the national drug situation
A summary of the national drug situation
India AIDS Response Report 2014
(Health Systems in Transition, Vol. 4, No. 3, 2014)
